Journal Mobile Options
Table of Contents
Vol. 18, No. 1, 2001
Issue release date: January 2001
Section title: Original Paper
Exp Clin Immunogenet 2001;18:42–50
(DOI:10.1159/000049086)

Genomic Analysis of Idiopathic Infertile Patients with Sperm-Specific Depletion of CD46

Nomura M.a · Kitamura M.b · Matsumiya K.b · Tsujimura A.b · Okuyama A.b · Matsumoto M.a · Toyoshima K.a · Seya T.a
aDepartment of Immunology, Osaka Medical Center for Cancer, Osaka, and bDepartment of Urology, Osaka University Medical School, Suita, Osaka, Japan

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

For eJournal Archive and eJournal Backfiles information please contact service@karger.com


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: 1/11/2001
Issue release date: January 2001

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 0

ISSN: 0254-9670 (Print)
eISSN: 1421-9948 (Online)

For additional information: http://www.karger.com/ECI

Abstract

Three infertile subjects with no expression of CD46 (membrane cofactor protein of complement) on their spermatozoa were found when screening 542 idiopathic male infertile patients. The sperm CD46 isoform was reported to be associated with the sperm-egg interaction, yet a ubiquitous expression of CD46 confers resistance to complement-mediated injury on host cells. All three patients expressed normal CD46 isoforms on their lymphocytes and granulocytes. Thus, the loss of CD46 is sperm-specific, probably due to testicular germ cell-specific regulation of CD46 production. Recently, a mechanism of the gene regulation of human CD46 was elucidated in which the silencer element of the 3′ UT and the promoter region of human CD46 gene partly participate. Here, we analyzed these regions of the CD46 gene in our 3 patients. We found no abnormality in 3′ and 5′ regions of the CD46 genome in the 3 patients. Thus, in these infertile patients sperm-specific depletion of CD46 is not governed by the so for identified regulators in the CD46 gene. Other unknown factors outside the known regulatory regions would play a role in the regulation of sperm-specific CD46 expression.

© 2001 S. Karger AG, Basel


  

Author Contacts

Dr. Tsukasa Seya
Department of Immunology
Osaka Medical Center for Cancer
Higashinari-ku, Osaka 537 (Japan)
Tel./Fax +81 6 6973 1209

  

Article Information

Received: Received: June 10, 2000
Number of Print Pages : 9
Number of Figures : 3, Number of Tables : 0, Number of References : 22

  

Publication Details

Experimental and Clinical Immunogenetics

Vol. 18, No. 1, Year 2001 (Cover Date: Released January 2001)

Journal Editor: K. Bauer, Heidelberg
ISSN: 0254–9670 (print), 1421–9948 (Online)

For additional information: http://www.karger.com/journals/eci


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: 1/11/2001
Issue release date: January 2001

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 0

ISSN: 0254-9670 (Print)
eISSN: 1421-9948 (Online)

For additional information: http://www.karger.com/ECI


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.